TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05067127 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT06240754 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT05521178 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06240728 — Predictive Biomarker (PRD): HHLA2 mRNA
Genes: HHLA2
Study NCT04833881 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05921474 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05516173 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05315778 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05949320 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04770545 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03206931 — Pharmacodynamic Biomarker (PDY): Tropomyosin-related kinase A
Genes: NTRK1; MTC; TRK; TRKA
Study NCT03206931 — Predictive Biomarker (PRD): NTRK2 mRNA
Genes: NTRK2; TRKB
Study NCT03206931 — Predictive Biomarker (PRD): NTRK3 mRNA
Genes: NTRK3; TRKC
Study NCT05657171 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06637384 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06643000 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06643000 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06643000 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06643000 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06637085 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05149469 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT05986695 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04965064 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06141993 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06141993 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT05020769 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT05020769 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04624399 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06641648 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06640049 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06637956 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06047262 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT06643182 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06351020 — Predictive Biomarker (PRD): CLDN18 mRNA
Genes: CLDN18; UNQ778/PRO1572
Study NCT05045417 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05045417 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06326866 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT05068713 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06515106 — Predictive Biomarker (PRD): LGI1 mRNA
Genes: LGI1; EPT; UNQ775/PRO1569
Study NCT06555224 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05054439 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT04542590 — Predictive Biomarker (PRD): PHC3 mRNA
Genes: PHC3; EDR3; PH3
Study NCT04925804 — Predictive Biomarker (PRD): ALPL mRNA
Genes: ALPL
Study NCT06178315 — Predictive Biomarker (PRD): CPB1 mRNA
Genes: CPB1; CPB; PCPB
Study NCT06690840 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05937906 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05901207 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05901207 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05901207 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study NCT05901207 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study NCT05901207 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT05901207 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT05358717 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT06460519 — Predictive Biomarker (PRD): AGTRAP mRNA
Genes: AGTRAP; ATRAP
Study NCT05428345 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04802109 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06569472 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06572020 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06289582 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT05623995 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT05564988 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Placenta growth factor
Genes: PGF; PGFL; PLGF
Study NCT05564988 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05950113 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05950113 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04054180 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02758730 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT02758730 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT06284681 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06641674 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06561243 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05849246 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05447013 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06639672 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06639672 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06639672 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06639672 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06638541 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT06092931 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06092931 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT06399107 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06399107 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06451458 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05479981 — Predictive Biomarker (PRD): DMPK mRNA
Genes: DMPK; DM1PK; MDPK
Study NCT05895929 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT06635850 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT04697069 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04697069 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT06613425 — Predictive Biomarker (PRD): ABO mRNA
Genes: ABO
Study NCT06007157 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05015049 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06630221 — Predictive Biomarker (PRD): TET2 mRNA
Genes: TET2; KIAA1546; Nbla00191
Study NCT05492045 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06638580 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06638580 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT06644495 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06703424 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06714617 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06713096 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study NCT06711094 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06076135 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06640036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06259812 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06713798 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04933422 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04933422 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04953026 — Predictive Biomarker (PRD): SLMAP mRNA
Genes: SLMAP; KIAA1601; SLAP; UNQ1847/PRO3577
Study NCT06507657 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT06690736 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT06689423 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05479045 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04783428 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT05507853 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT06105255 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT06105255 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study NCT06105255 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT06105255 — Predictive Biomarker (PRD): SLCO1B3 mRNA
Genes: SLCO1B3; LST2; OATP1B3; OATP8; SLC21A8
Study NCT05912400 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06060509 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT06060509 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT06060509 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT04802590 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06563804 — Predictive Biomarker (PRD): CD74 mRNA
Genes: CD74; DHLAG
Study NCT05558267 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05558267 — Surrogate Endpoint (SUR): Serum potassium
Study NCT06507644 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT05552573 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06443242 — Predictive Biomarker (PRD): CORT mRNA
Genes: CORT; UNQ307/PRO350
Study NCT05779956 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06571474 — Predictive Biomarker (PRD): TFEB mRNA
Genes: TFEB; BHLHE35
Study NCT06629857 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05903989 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT00002171 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05506111 — Predictive Biomarker (PRD): LARS1 mRNA
Genes: LARS1; KIAA1352; LARS
Study NCT06054308 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT06168006 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06294899 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05586282 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05231915 — Predictive Biomarker (PRD): HOXB13 mRNA
Genes: HOXB13
Study NCT05597124 — Predictive Biomarker (PRD): ABCA7 mRNA
Genes: ABCA7
Study NCT06284304 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT06644079 — Predictive Biomarker (PRD): CDCP1 mRNA
Genes: CDCP1; TRASK; UNQ2486/PRO5773
Study NCT06644079 — Pharmacodynamic Biomarker (PDY): Signal transducer and activator of transcription 3
Genes: STAT3; APRF
Study NCT06644079 — Predictive Biomarker (PRD): ATF4 mRNA
Genes: ATF4; CREB2; TXREB
Study NCT06641544 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06636695 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06638515 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06643780 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK
Study NCT06643130 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06643130 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06082843 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06258564 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04139304 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT05484557 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04913116 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05051228 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06112275 — Predictive Biomarker (PRD): SCN1A mRNA
Genes: SCN1A; NAC1; SCN1
Study NCT06199752 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05393427 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05144737 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06332339 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT05136027 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04825600 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05103332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06418516 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06027905 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06240039 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT06662695 — Predictive Biomarker (PRD): ABCA1 mRNA
Genes: ABCA1; ABC1; CERP
Study NCT06662695 — Predictive Biomarker (PRD): ABCG1 mRNA
Genes: ABCG1; ABC8; WHT1
Study NCT06675591 — Surrogate Endpoint (SUR): Serum sodium
Study NCT06027398 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05892393 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study NCT05795829 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06196190 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06305403 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT06637514 — Surrogate Endpoint (SUR): Plasma phenylalanine
Study NCT05886244 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT05886244 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT05581511 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT06636799 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06640283 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06640283 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06643468 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT06643442 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06643585 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06643585 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06643585 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06252506 — Predictive Biomarker (PRD): DMTN mRNA
Genes: DMTN; DMT; EPB49
Study NCT05866640 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study NCT05626322 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05626322 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06124924 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05407636 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05407636 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06274840 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06314256 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06189742 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT06189742 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05090865 — Surrogate Endpoint (SUR): Serum potassium
Study NCT05090865 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04968834 — Predictive Biomarker (PRD): PAFAH1B1 mRNA
Genes: PAFAH1B1; LIS1; MDCR; MDS; PAFAHA
Study NCT05064618 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study NCT00000709 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06564740 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05022654 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT05647356 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05647356 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04809805 — Predictive Biomarker (PRD): SLFN12 mRNA
Genes: SLFN12
Study NCT04809805 — Predictive Biomarker (PRD): PDE3A mRNA
Genes: PDE3A
Study NCT06524180 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06161064 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06018519 — Predictive Biomarker (PRD): SLC6A8 mRNA
Genes: SLC6A8
Study NCT06252584 — Predictive Biomarker (PRD): TLR1 mRNA
Genes: TLR1; KIAA0012
Study NCT05982678 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05513573 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05668624 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05290415 — Predictive Biomarker (PRD): CDO1 mRNA
Genes: CDO1
Study NCT05290415 — Predictive Biomarker (PRD): CELF4 mRNA
Genes: CELF4; BRUNOL4
Study NCT05802134 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06185751 — Predictive Biomarker (PRD): SLAMF7 mRNA
Genes: SLAMF7; CS1; UNQ576/PRO1138
Study NCT06569732 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT04990791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04990791 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05288920 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06265415 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05313373 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05646693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05646693 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05646693 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05646693 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06439810 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04458766 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT06638034 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT06640270 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06644313 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06644313 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT06113809 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06271057 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05628480 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06196034 — Predictive Biomarker (PRD): ADAM33 mRNA
Genes: ADAM33; C20orf153; UNQ873/PRO1891
Study NCT06196034 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06196034 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05168293 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05187767 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04849273 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05622032 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT06286163 — Predictive Biomarker (PRD): P2RX2 mRNA
Genes: P2RX2; P2X2
Study NCT05706350 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05026801 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06317909 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT06643091 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT06643091 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06641609 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06320782 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT05826626 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05826626 — Safety Biomarker (SAF): BDNF
Study NCT06206837 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06206837 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06585384 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05549297 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05549297 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05834738 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05382130 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04630769 — Predictive Biomarker (PRD): FATE1 mRNA
Genes: FATE1; FATE
Study NCT04630769 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06608303 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06037811 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05984966 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06626126 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06051357 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT06305390 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06518655 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05152823 — Predictive Biomarker (PRD): IGHMBP2 mRNA
Genes: IGHMBP2; SMBP2; SMUBP2